Back to the Teratology Society home page
Publications
Newsletters
Constitution and Bylaws
Minutes
 

Council

 

Business

 

Strat. Planning 2002

Birth Defects Research
Other Journals of interest
Teratogen Updates
Teratology Society Position Papers
Books Authored by Society Members
Miscellaneous Documents


Back to the Teratology Society home page Contact the Teratology Society

Response to NIEHS' 2006 Strategic Plan

Questions:



  1. Reproductive and Developmental Toxicity; specifically, the developmental origins of health and disease resulting from exposure to environmental chemicals early in life, defined here as exposure during prenatal, infantile or early childhood development. Epidemiological evidence is suggesting that developmental diseases should be considered in a broad context inclusive of birth defects (congenital malformations, functional deficits, developmental disabilities), altered sexual development or reproductive function (endocrine disruption), impacts on health during early life (cognitive learning), and chronic diseases that manifest later in life (fetal basis of adult disease). Risk factors from exposure to environmental chemicals generally depend on the nature of the chemical, the route and dose-rate of exposure, and the genetics, age and susceptibility of the individual. The emerging evidence from basic research suggests an emphasis on epigenetic mechanisms can lead to fruitful applications. When addressing developmental processes and toxicities the quality of the intrauterine environment and the developmental programming / re-programming of target cell populations should also be considered. Therefore, developmental health and disease is a special public health response of NIEHS-related research that requires careful attention to different periods of development as a major factor in disease phenotypes. To understand the fundamental mechanisms of environmental injury and disease from a developmental perspective requires targeted outreach to young children, pregnant and lactating women, and women of reproductive age. Understanding these fundamental mechanisms is also a prerequisite for public and private decision makers as remediation strategies are assessed.



  2. High-throughput (HTP) genomic, proteomic, and metabolomic technologies, together with the availability of sequence information from a growing number of human and model organisms, have paved the way to a deeper understanding of biological systems and their disruption during the course of disease. Integrating the HTP data stream (systems biology) should be further embraced to identify preclinical markers to help understand the biology and genetics of complex environmentally related diseases that affect developmental health and disease. Specifically, research is needed to link these biomarkers with critical developmental pathways and embryological regulatory networks that are targets for effects caused by disease-based environmental toxicants. Creating realistic and sensible computational / working models of developing systems can enable newer methods and technologies in complexity science and artificial intelligence, to learn how environmental exposures result in developmental disease. The computational and bioinformatics infratsructure to do this must be expanded in an environmental context. We need tools to help us undertsand how complex exposures, in interaction with genetic factors



  3. Although systems biology may help us understand biological processes, they must be placed within the context of human disease. The applications of systems theory to population studies and basic biomedical research will require new mathematical tools and algorithms to address the developmental theme. The facilities and competencies available to apply the science of complexity to developing systems is insufficient at present time. In this regard, we must continue to encourage mathematical researchers to work closely with biomedical researchers to theorize and implement formal models of complex network behavior. Just as multiple risk conditions contribute to the continuum of casualty that has more significant and negative impacts on development than are produced by individual risk conditions, so it is true that multiple, diverse cellular signaling pathways forming "biological regulatory networks" will likely affect the system as a whole in ways not intuitively obvious from the individual pathway characteristics. Systems-level thinking can be applied not only to biological data, but to the people and organizations that constitute a complex network. Unraveling complex systems is a central paradigm for modern systems biology should be strongly encouraged not only as a fundamental cell-based research paradigm but also at a more global, population level to prioritize global environmental health issues.



  4. The folic acid story would suggest that we should put more emphasis on “exposures” that prevent birth defects as we continue to search for exposures that cause birth defects. Thus “dietary exposures” need more consideration. In addition, more research is needed concerning “protective signaling pathways,” e.g., stress response pathways, that may offer possibilities for therapeutic intervention.



  5. Understanding the etiology of birth defects, whether caused by genes, environmental exposures, or a combination genes and exposures, requires practitioners who are broadly trained. Thus, the most critical needs for training the next generation of developmental toxicologists are to provide the diversity of training necessary to tackle the key problems in developmental toxicology. This diversity encompasses training in embryology/developmental biology, molecular biology, epidemiology, chemistry, and mathematics. Clearly, no one individual can hope to develop expertise in all of these areas; therefore, training programs need to be developed that provide an individual with expertise in one or two areas with additional training in one or two other areas.



  6. Available evidence suggests that the interaction of genes and the environment underlies the majority of birth defects in humans. This interaction, which can occur at multiple times during the dynamic development of the human embryo, is thought to involve many, if not all, of the signaling pathways available to vertebrate animals. Thus, understanding the temporal changes in complex signaling pathways will require new technologies capable of capturing this complexity. To achieve this, two developments are necessary. One is the continued development of the “systems biology” approach. The other is the creation of new ways of encouraging interdisciplinary research in systems biology.


The above comments have been submitted with general input solicited from the Teratology Society.

 

Rev. 10-Aug-2005
© Copyright Teratology Society 1998-2004, 2005.
Please read our disclaimer.